Search results
Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Re
Guru Focus· 6 days agoOn May 2, 2024, Shattuck Labs Inc (STTK, Financial), a trailblazer in bi-functional fusion protein technology, disclosed its financial outcomes for the first quarter ended March 31, 2024, through ...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q1 2024 Earnings Call Transcript May 7, 2024 Rigel...
Colby Schrenk has wish granted to go to Walt Disney World
The Jamestown Sun, N.D. via Yahoo News· 7 days agoMay 3—JAMESTOWN — When Ypsilanti native Colby Schrenk was asked what he wanted his wish to be through the Make-A-Wish North Dakota, his answer was easy: to go to Walt Disney World in Orlando ...
2 Gresham firefighters to be honored at national memorial ceremony
KOIN via Yahoo News· 6 days agoAmong the honorees is Brian Flowers, a firefighter and EMT who served the City of Gresham for 15...
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 2 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
Leukemia Therapeutics Market Expected to Grow at USD 13491.42 Million by 2030: SNS Insider
Digital Journal· 7 days agoThe global leukemia therapeutics market has witnessed significant growth in recent years, driven by...
2 Gresham firefighters to be honored at national memorial ceremony
KOIN News 6 Portland· 6 days agoTwo fallen Gresham firefighters are set to be honored for their service in a national ceremony in...
GlycoMimetics fails phase 3 blood cancer trial, causing investors to sour on stock
FierceBiotech· 4 days agoMonday, GlycoMimetics reported the failure of the trial—spurring a 72% stock drop that crushed the company's share price to 51 cents in premarket trading Monday morning, compared to $1.83 at ...
Why Is GlycoMimetics (GLYC) Stock Down 77% Today?
InvestorPlace· 4 days agoGlycoMimetics (NASDAQ:GLYC) stock is taking a beating on Monday after the biotechnology company announced results from a Phase 3 clinical trial....
Dow Surges Over 100 Points; EyePoint Pharmaceuticals Shares Plunge - Spirit Airlines (NYSE:SAVE)
Benzinga· 4 days agoShares of GlycoMimetics, Inc GLYC were down 82% to $0.3330 after the company announced topline...